Plotted Points Statistics |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 102% | 20% | 106% | 24% |
>= Reporting Level | 18 | 90% | 25% | 93% | 15% |
Total | 22 | 92% | 24% | 96% | 20% |
Sample Statistics |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 22 | 88% | Spiked |
Estimated Values | 2 | 8% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 8% | Spiked |
Spiked | 26 | . | |
False Negatives | 1 | 4% | 1 out of 25 |
Not Spiked | 21 | . | |
False Positives | 0 | 0% | 0 out of 21 |
Plotted Points Statistics |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 80% | 11% | 78% | 12% |
>= Reporting Level | 18 | 83% | 12% | 83% | 8% |
Total | 22 | 82% | 11% | 82% | 12% |
Sample Statistics |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 22 | 88% | Spiked |
Estimated Values | 2 | 8% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 4% | Spiked |
Spiked | 26 | . | |
False Negatives | 2 | 8% | 2 out of 25 |
Not Spiked | 21 | . | |
False Positives | 0 | 0% | 0 out of 21 |
Plotted Points Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 71% | 6% | 69% | 9% |
>= Reporting Level | 18 | 83% | 16% | 80% | 16% |
Total | 21 | 81% | 15% | 78% | 15% |
Sample Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 21 | 81% | Spiked |
Estimated Values | 2 | 8% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 12% | Spiked |
Spiked | 27 | . | |
False Negatives | 2 | 8% | 2 out of 26 |
Not Spiked | 20 | . | |
False Positives | 0 | 0% | 0 out of 20 |
Plotted Points Statistics |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 24 | 80% | 7% | 79% | 8% |
Total | 24 | 80% | 7% | 79% | 8% |
Sample Statistics |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 24 | 92% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 27 | . | |
False Negatives | 2 | 8% | 2 out of 26 |
Not Spiked | 20 | . | |
False Positives | 3 | 15% | 3 out of 20 |
Plotted Points Statistics |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 21 | 67% | 22% | 71% | 13% |
Total | 21 | 67% | 22% | 71% | 13% |
Sample Statistics |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 21 | 84% | Spiked |
Estimated Values | 2 | 8% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 26 | . | |
False Negatives | 4 | 16% | 4 out of 25 |
Not Spiked | 21 | . | |
False Positives | 0 | 0% | 0 out of 21 |
Plotted Points Statistics |
4,4BISPHENOL F |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 6 | 70% | 19% | 74% | 26% |
Total | 6 | 70% | 19% | 74% | 26% |
Sample Statistics |
4,4BISPHENOL F |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 6 | 100% | Spiked |
Estimated Values | 6 | 100% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 6 | . | |
False Negatives | 0 | 0% | 0 out of 6 |
Not Spiked | 41 | . | |
False Positives | 0 | 0% | 0 out of 40 |
Plotted Points Statistics |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 43% | . | 43% | 0% |
>= Reporting Level | 11 | 56% | 13% | 57% | 9% |
Total | 12 | 55% | 13% | 56% | 11% |
Sample Statistics |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 12 | 71% | Spiked |
Estimated Values | 1 | 6% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 12% | Spiked |
Spiked | 17 | . | |
False Negatives | 3 | 18% | 3 out of 17 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 29 |
Plotted Points Statistics |
BISPHENOL A |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 27 | 73% | 12% | 72% | 11% |
Total | 27 | 73% | 12% | 72% | 11% |
Sample Statistics |
BISPHENOL A |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 100% | Spiked |
Estimated Values | 27 | 100% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 28 | . | |
False Negatives | 0 | 0% | 0 out of 27 |
Not Spiked | 19 | . | |
False Positives | 0 | 0% | 0 out of 19 |
Plotted Points Statistics |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 27 | 76% | 20% | 81% | 16% |
Total | 27 | 76% | 20% | 81% | 16% |
Sample Statistics |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 100% | Spiked |
Estimated Values | 4 | 15% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 28 | . | |
False Negatives | 0 | 0% | 0 out of 27 |
Not Spiked | 19 | . | |
False Positives | 0 | 0% | 0 out of 19 |
Plotted Points Statistics |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 28 | 55% | 6% | 56% | 5% |
Total | 28 | 55% | 6% | 56% | 5% |
Sample Statistics |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 97% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 29 | . | |
False Negatives | 1 | 3% | 1 out of 29 |
Not Spiked | 18 | . | |
False Positives | 0 | 0% | 0 out of 17 |
Plotted Points Statistics |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 16 | 66% | 18% | 69% | 7% |
Total | 16 | 66% | 18% | 69% | 7% |
Sample Statistics |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 16 | 89% | Spiked |
Estimated Values | 3 | 17% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 6% | Spiked |
Spiked | 18 | . | |
False Negatives | 1 | 6% | 1 out of 18 |
Not Spiked | 29 | . | |
False Positives | 0 | 0% | 0 out of 28 |
Plotted Points Statistics |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 17 | 70% | 24% | 75% | 13% |
Total | 17 | 70% | 24% | 75% | 13% |
Sample Statistics |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 17 | 94% | Spiked |
Estimated Values | 3 | 17% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 18 | . | |
False Negatives | 1 | 6% | 1 out of 18 |
Not Spiked | 29 | . | |
False Positives | 0 | 0% | 0 out of 28 |
Plotted Points Statistics |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 12 | 88% | 57% | 52% | 68% |
Total | 12 | 88% | 57% | 52% | 68% |
Sample Statistics |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 12 | 100% | Spiked |
Estimated Values | 2 | 17% | Spiked |
Deleted Values | 1 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 13 | . | |
False Negatives | 0 | 0% | 0 out of 12 |
Not Spiked | 19 | . | |
False Positives | 5 | 26% | 5 out of 19 |
Plotted Points Statistics |
EQUILIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 26 | 47% | 16% | 51% | 16% |
Total | 26 | 47% | 16% | 51% | 16% |
Sample Statistics |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 26 | 96% | Spiked |
Estimated Values | 26 | 96% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 28 | . | |
False Negatives | 1 | 4% | 1 out of 27 |
Not Spiked | 19 | . | |
False Positives | 0 | 0% | 0 out of 19 |
Plotted Points Statistics |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 26 | 76% | 12% | 80% | 14% |
Total | 26 | 76% | 12% | 80% | 14% |
Sample Statistics |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 26 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 27 | . | |
False Negatives | 0 | 0% | 0 out of 26 |
Not Spiked | 20 | . | |
False Positives | 0 | 0% | 0 out of 20 |
Plotted Points Statistics |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 28 | 66% | 9% | 64% | 9% |
Total | 28 | 66% | 9% | 64% | 9% |
Sample Statistics |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 97% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 29 | . | |
False Negatives | 1 | 3% | 1 out of 29 |
Not Spiked | 18 | . | |
False Positives | 0 | 0% | 0 out of 17 |
Plotted Points Statistics |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 32% | . | 32% | 0% |
>= Reporting Level | 17 | 40% | 8% | 41% | 6% |
Total | 18 | 40% | 8% | 40% | 7% |
Sample Statistics |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 18 | 69% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 4 | 15% | Spiked |
Spiked | 27 | . | |
False Negatives | 4 | 15% | 4 out of 26 |
Not Spiked | 20 | . | |
False Positives | 0 | 0% | 0 out of 20 |
Plotted Points Statistics |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 80% | 7% | 79% | 8% |
>= Reporting Level | 17 | 72% | 18% | 72% | 10% |
Total | 21 | 74% | 17% | 74% | 8% |
Sample Statistics |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 21 | 84% | Spiked |
Estimated Values | 2 | 8% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 4% | Spiked |
Spiked | 26 | . | |
False Negatives | 3 | 12% | 3 out of 25 |
Not Spiked | 21 | . | |
False Positives | 0 | 0% | 0 out of 21 |
Plotted Points Statistics |
PROGESTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 26 | 38% | 11% | 37% | 9% |
Total | 26 | 38% | 11% | 37% | 9% |
Sample Statistics |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 26 | 90% | Spiked |
Estimated Values | 26 | 90% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 29 | . | |
False Negatives | 3 | 10% | 3 out of 29 |
Not Spiked | 18 | . | |
False Positives | 0 | 0% | 0 out of 17 |
Plotted Points Statistics |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 75% | 18% | 71% | 20% |
>= Reporting Level | 12 | 70% | 18% | 71% | 18% |
Total | 16 | 72% | 17% | 71% | 18% |
Sample Statistics |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 16 | 62% | Spiked |
Estimated Values | 1 | 4% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 8% | Spiked |
Spiked | 27 | . | |
False Negatives | 8 | 31% | 8 out of 26 |
Not Spiked | 20 | . | |
False Positives | 5 | 25% | 5 out of 20 |